KR100794915B1 - 목초액과 알파히드록시산을 함유하는 화장료 조성물 - Google Patents
목초액과 알파히드록시산을 함유하는 화장료 조성물 Download PDFInfo
- Publication number
- KR100794915B1 KR100794915B1 KR1020010078035A KR20010078035A KR100794915B1 KR 100794915 B1 KR100794915 B1 KR 100794915B1 KR 1020010078035 A KR1020010078035 A KR 1020010078035A KR 20010078035 A KR20010078035 A KR 20010078035A KR 100794915 B1 KR100794915 B1 KR 100794915B1
- Authority
- KR
- South Korea
- Prior art keywords
- wood vinegar
- alpha hydroxy
- skin
- hydroxy acid
- cosmetic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000052 vinegar Substances 0.000 title claims abstract description 29
- 235000021419 vinegar Nutrition 0.000 title claims abstract description 29
- 239000002023 wood Substances 0.000 title claims abstract description 28
- 239000002537 cosmetic Substances 0.000 title claims abstract description 24
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 229940061720 alpha hydroxy acid Drugs 0.000 title abstract description 29
- 150000001280 alpha hydroxy acids Chemical class 0.000 title abstract description 29
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 title abstract description 10
- 229960000583 acetic acid Drugs 0.000 title abstract description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 44
- 239000004310 lactic acid Substances 0.000 claims description 22
- 235000014655 lactic acid Nutrition 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- 238000010000 carbonizing Methods 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- YXGJEZRSNHUDFV-UHFFFAOYSA-M potassium;2-hydroxybutanoate Chemical compound [K+].CCC(O)C([O-])=O YXGJEZRSNHUDFV-UHFFFAOYSA-M 0.000 claims description 2
- 239000000779 smoke Substances 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 27
- 230000006872 improvement Effects 0.000 abstract description 14
- 238000004299 exfoliation Methods 0.000 abstract description 13
- 230000003712 anti-aging effect Effects 0.000 abstract description 8
- 230000003020 moisturizing effect Effects 0.000 abstract description 6
- 206010014970 Ephelides Diseases 0.000 abstract description 5
- 208000003351 Melanosis Diseases 0.000 abstract description 5
- 208000012641 Pigmentation disease Diseases 0.000 abstract description 5
- 206010040880 Skin irritation Diseases 0.000 abstract description 5
- 230000019612 pigmentation Effects 0.000 abstract description 5
- 230000036556 skin irritation Effects 0.000 abstract description 5
- 231100000475 skin irritation Toxicity 0.000 abstract description 5
- 230000037303 wrinkles Effects 0.000 abstract description 5
- 230000000774 hypoallergenic effect Effects 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 7
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 230000007306 turnover Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 229940120503 dihydroxyacetone Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000012657 Atopic disease Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241001340526 Chrysoclista linneella Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940053991 aldehydes and derivative Drugs 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- DDPAAMHROJBRGE-UHFFFAOYSA-N butane-1,4-diol;propane-1,2-diol Chemical compound CC(O)CO.OCCCCO DDPAAMHROJBRGE-UHFFFAOYSA-N 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- -1 glycerin-26 Chemical compound 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
- A61K2800/72—Hypo-allergenic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
구분 | 원 료 명 | 함 량(중량부) | ||||||
실시예1 | 실시예2 | 실시예3 | 비교예1 | 비교예2 | 비교예3 | 비교예4 | ||
수상 | 정제수 프로필렌글리콜 부틸렌글리콜 카보머 에탄올 목초액 락틱산 | To100 2.0 5.0 0.2 10.0 0.5 0.1 | To100 2.0 5.0 0.2 10.0 5.0 1.0 | To100 2.0 5.0 0.2 10.0 10.0 5.0 | To100 2.0 5.0 0.2 10.0 - 0.1 | To100 2.0 5.0 0.2 10.0 - 1.0 | To100 2.0 5.0 0.2 10.0 - 5.0 | To100 2.0 5.0 0.2 10.0 - - |
유상 | 세틸옥타노에이트 사이클로메티콘 유동파라핀 폴리솔베이트 60 솔비탄스테아레이트 | 4.0 3.0 4.0 5.0 3.0 | 4.0 3.0 4.0 5.0 3.0 | 4.0 3.0 4.0 5.0 3.0 | 4.0 3.0 4.0 5.0 3.0 | 4.0 3.0 4.0 5.0 3.0 | 4.0 3.0 4.0 5.0 3.0 | 4.0 3.0 4.0 5.0 3.0 |
첨가제 | 향 방부제 | 적량 적량 | 적량 적량 | 적량 적량 | 적량 적량 | 적량 적량 | 적량 적량 | 적량 적량 |
그룹 1 | 그룹 2 | 그룹 3 | 그룹 4 | 그룹 5 | 그룹 6 | 그룹 7 | |
Turnover day(일) | 18.9 | 16.6 | 14.8 | 19.8 | 17.4 | 15.2 | 21.7 |
실시예 1 | 실시예 2 | 실시예 3 | 비교예 1 | 비교예 2 | 비교예 3 | 비교예 4 | |
Stinging(따끔거림) Score | 0.21 | 0.33 | 0.37 | 0.35 | 0.84 | 1.74 | 0.15 |
Claims (2)
- 목초액 0.01-10 중량%와 락틱산, 글리콜산, 젖산, 말산, 히드록시부틴산칼륨 중에서 선택되는 1종 이상을 0.01-20 중량% 함유함을 특징으로하는 화장료 조성물.
- 제 1항에 있어서, 목초액은 참나무를 500-700도로 탄화 시 발생하는 연기와 수증기를 응축수로 냉각하여 얻은 응축수를 5-20배의 물로 희석하여 만든 것임을 특징으로 하는 화장료 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010078035A KR100794915B1 (ko) | 2001-12-11 | 2001-12-11 | 목초액과 알파히드록시산을 함유하는 화장료 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010078035A KR100794915B1 (ko) | 2001-12-11 | 2001-12-11 | 목초액과 알파히드록시산을 함유하는 화장료 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030047502A KR20030047502A (ko) | 2003-06-18 |
KR100794915B1 true KR100794915B1 (ko) | 2008-01-14 |
Family
ID=29574136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020010078035A Expired - Fee Related KR100794915B1 (ko) | 2001-12-11 | 2001-12-11 | 목초액과 알파히드록시산을 함유하는 화장료 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100794915B1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030005075A (ko) * | 2002-10-17 | 2003-01-15 | 장명수 | 목초액을 혼합하는 화장료 조성물. |
KR20050099223A (ko) * | 2004-04-09 | 2005-10-13 | 안봉전 | 목초액을 유효 성분으로 하는 화장품 조성물 및 이의용도와 이를 이용한 헤어토닉 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001054656A1 (en) * | 2000-01-27 | 2001-08-02 | P&G-Clairol, Inc. | Novel primary intermediate for use in oxidative hair dyeing |
-
2001
- 2001-12-11 KR KR1020010078035A patent/KR100794915B1/ko not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001054656A1 (en) * | 2000-01-27 | 2001-08-02 | P&G-Clairol, Inc. | Novel primary intermediate for use in oxidative hair dyeing |
Also Published As
Publication number | Publication date |
---|---|
KR20030047502A (ko) | 2003-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8496948B2 (en) | Topical skin composition comprising mineral yeast ferments | |
CN106511135B (zh) | 一种美白复方精油及其制备方法 | |
EP1471874A4 (en) | COMPOSITIONS AND METHODS OF TREATING WRINKLES, DELICACIES AND HYPERHIDROSIS | |
KR102326796B1 (ko) | 피부 항산화 및 피부 진정 효과가 있는 화장료 조성물, 이를 이용한 화장료 및 이의 제조방법 | |
WO2008139182A2 (en) | Skin care composition | |
KR102253095B1 (ko) | 여드름 피부 개선 화장료, 이의 제조방법 및 이를 포함하는 여드름 피부 개선 기능성 화장품 | |
KR101055963B1 (ko) | 각질 박리 촉진용 화장료 조성물 | |
JP2005187474A (ja) | 改善された香粧料 | |
JPH0566922B2 (ko) | ||
KR101744889B1 (ko) | 항산화, 미백 및 주름개선 효과를 갖는 조성물 | |
KR20020043339A (ko) | 매실의 다알코올류 추출물을 함유하는 화장품 조성물 | |
US20140227204A1 (en) | Skin compositions containing hydrocortisone | |
KR102611907B1 (ko) | 스피큘 추출물을 함유한 기능성 화장품 조성물 및 이의 제조 방법 | |
CN103494737A (zh) | 一种以姜花作为抗衰老护肤因子的化妆品制剂及制备方法 | |
KR100794915B1 (ko) | 목초액과 알파히드록시산을 함유하는 화장료 조성물 | |
KR100490172B1 (ko) | 백급으로부터 추출 분리된 천연 다당류를 함유하는 화장료조성물 | |
Tanuwidjaja | Development of Anti-Aging Cream Preparations with Active Substances from Plant Extracts: Physicochemical Review and Potential Applications | |
KR100548033B1 (ko) | 화장료 조성물 | |
KR101154772B1 (ko) | 대추 추출물 및 호두 추출물을 함유하는 피부 보습용화장료 조성물 | |
CN104188808A (zh) | 一种祛斑祛黄凝胶及其制备方法 | |
JP2005029556A (ja) | 皮膚老化防止剤 | |
KR100444196B1 (ko) | 나노리포좀으로 안정화된 약용식물 복합 추출액 함유화장료 조성물 | |
KR20050098583A (ko) | 옥죽 파우더를 함유하는 피부보습용 화장료 조성물 | |
CN109464311A (zh) | 一种美白抗敏抗衰老复方精油及其制备方法 | |
Wolf et al. | An alpha hydroxy acid derivative suitable for sensitive skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20011211 |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20061115 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20011211 Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20070922 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20071228 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20080108 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20080108 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20101222 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20111230 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20121221 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20121221 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20131230 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20131230 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20141226 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20141226 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20151229 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20151229 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20161227 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20161227 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20171227 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20171227 Start annual number: 11 End annual number: 11 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20191019 |